Dimensional Fund Advisors
NAGE

Dimensional Fund Advisors’s Niagen Bioscience NAGE Stock Holding History

Dimensional Fund Advisors’s Portfolio NAGE Stock Details NAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.93M Sell
605,326
-465,807
-43% -$1.89M ﹤0.01% 2752
2026
Q1 		$4.72M Buy
1,071,133
+150,763
+16% +$814K ﹤0.01% 2513
2025
Q4 		$5.85M Buy
920,370
+194,647
+27% +$1.35M ﹤0.01% 2481
2025
Q3 		$6.77M Buy
725,723
+382,825
+112% +$3.87M ﹤0.01% 2445
2025
Q2 		$4.94M Buy
342,898
+161,799
+89% +$1.6M ﹤0.01% 2522
2025
Q1 		$1.25M Buy
181,099
+58,177
+47% +$366K ﹤0.01% 2831
2024
Q4 		$652K Buy
122,922
+54,969
+81% +$301K ﹤0.01% 2993
2024
Q3 		$248K Buy
67,953
+35,842
+112% +$113K ﹤0.01% 3135
2024
Q2 		$87.7K Buy
+32,111
New +$107K ﹤0.01% 3264

Other funds holding NAGE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
Tieton Capital Management Yakima, Washington $348M AUM 45.13% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Dimensional Fund Advisors's NAGE Position: Q2 2026 in Review

Dimensional Fund Advisors reduced its Niagen Bioscience (NAGE) stake by 43% in Q2 2026, selling an estimated $1.89M and leaving 605,326 shares worth $1.93M. The position accounts for ﹤0.01% of the portfolio, ranked #2752.

Dimensional Fund Advisors first reported a position in NAGE in Q2 2024 and has held it in 9 quarters since. The position peaked at $6.77M in Q3 2025. 140 funds tracked by Wall St. Rank hold NAGE as of Q2 2026.

  • Dimensional Fund Advisors held 605,326 shares of Niagen Bioscience worth $1.93M as of Q2 2026.
  • Dimensional Fund Advisors sold 465,807 Niagen Bioscience shares in Q2 2026, an estimated $1.89M.
  • Niagen Bioscience made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q2 2026, its #2752 holding.
  • Dimensional Fund Advisors first reported a position in Niagen Bioscience in Q2 2024 and has held it in 9 quarters since.
  • Dimensional Fund Advisors's Niagen Bioscience position peaked at $6.77M in Q3 2025.
  • 140 funds tracked by Wall St. Rank held Niagen Bioscience as of Q2 2026.

Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.